The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis
- 3 December 2017
- journal article
- review article
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 32 (12) , 758-774
Abstract
Background Despite the fact that aspirin is of benefit to patients following coronary artery bypass grafting (CABG), continuation or administration of preoperative aspirin before CABG or any cardiac surgical procedure remains controversial. Therefore, we performed a systematic review and meta‐analysis to assess the influence of preoperative aspirin administration on patients undergoing cardiac surgery. Materials and Methods Medline database was searched using OVID SP interface. Similar searches were performed separately in EMBASE, PubMed, and Cochrane Central Registry of Controlled Trials. Results Twelve randomized controlled trials and 28 observational studies met our inclusion criteria and were included in the meta‐analysis. The use of preoperative aspirin in patients undergoing CABG at any dose is associated with reduced early mortality as well as a reduced incidence of postoperative acute kidney injury (AKI). Low‐dose aspirin (≤160 mg/d) is associated with a decreased incidence of perioperative myocardial infarction (MI). Administration of preoperative aspirin at any dose in patients undergoing cardiac surgery increases postoperative bleeding. Despite this effect of preoperative aspirin, it did not increase the rates of surgical re‐exploration due to excessive postoperative bleeding nor did it increase the rates of packed red blood cell transfusions (PRBC) when preoperative low‐dose aspirin (≤160 mg/d) was administered. Conclusions Preoperative aspirin increases the risk for postoperative bleeding. However, this did not result in an increased need for chest re‐exploration and did not increase the rates of PRBC transfusion when preoperative low‐dose (≤160 mg/d) aspirin was administered. Aspirin at any dose is associated with decreased mortality and AKI and low‐dose aspirin (≤160 mg/d) decreases the incidence of perioperative MI.Keywords
This publication has 56 references indexed in Scilit:
- Timing of Preoperative Aspirin Discontinuation and Outcome After Elective Coronary Artery Bypass Graft SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2012
- Effects of Preoperative Aspirin on Cardiocerebral and Renal Complications in Non-Emergent Cardiac Surgery Patients: A Sub-Group and Cohort StudyPLOS ONE, 2012
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft SurgeryJACC, 2011
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Ischemic acute renal failure: An inflammatory disease?Kidney International, 2004
- Preoperative aspirin and heparin therapy does not increase perioperative blood loss and blood product requirements in coronary artery bypass graft surgeryJournal of Anesthesia, 1999
- Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with AspirinEuropean Journal of Cardio-Thoracic Surgery, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Preoperative Aspirin Ingestion Increases Operative Blood Loss after Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 1988
- Does Short-Term Pre-Operative Aspirin in Coronary Bypass Patients Increase Post-Operative Bleeding?Vascular Surgery, 1985